https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2006-12-04 13:49:342016-11-28 13:50:11Astex Therapeutics Appoints John Aston Chief Financial Officer
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2006-11-10 13:50:502016-11-28 13:51:11SuperGen Presents Preclinical Data on Selected Lead Kinase Compounds and DNA Methylation Inhibitor at EORTC
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2006-11-09 13:51:152016-11-28 13:51:41SuperGen Presents Preclinical Data at EORTC On MP-529, a Selective Kinase Inhibitor and CLIMB™ Process in Drug Discovery and Design
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2006-10-04 13:52:192016-11-28 13:52:45SuperGen COO to Leave Company at Year-End
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2006-08-23 13:53:272016-11-28 13:53:48Mayne Pharma’s Purchase of SuperGen’s North American Oncology Products Completes
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2006-07-27 13:54:292016-11-28 13:55:06New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Res
